Clinical Trials Browser

Phase 1 × Burkitt Lymphoma × S-1,2-dichlorovinyl-N-acetylcysteine × Clear all

NCT05262673 2022-03-08

NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL

Phase 1 Unknown

Burkitt Lymphoma